CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax of -$530.00 thousand for the 12-month period ending 2015-12-26, per its 10-K filed 2016-02-12.
Discontinued › Expense Statement › Income Tax
us-gaap:OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax · last filed 2016-02-12
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for the quarter ending 2015-12-26 was $170.00K, a 98.33% decline year-over-year.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for the quarter ending 2015-09-26 was -$220.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for the quarter ending 2015-06-27 was -$263.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for the quarter ending 2015-03-28 was -$217.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for fiscal 2015 was -$530.00K, a 105.41% decline from fiscal 2014.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for fiscal 2014 was $9.79M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for fiscal 2013 was -$8.00M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. other comprehensive (income) loss, defined benefit plan, after reclassification adjustment, tax for fiscal 2012 was -$1.58M.
| Period end | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 3 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 3 month as first filed | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 6 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 9 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 12 month | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, Tax 12 month as first filed |
|---|---|---|---|---|---|---|
| 2015-12-26 | $170.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$50.00K derived: sum of 2 quarters · filed 2016-02-12 | -$313.00K derived: sum of 3 quarters · filed 2016-02-12 | -$530.00K 10-K · filed 2016-02-12 | ||
| 2015-09-26 | -$220.00K 10-Q · filed 2015-11-04 | -$483.00K derived: sum of 2 quarters · filed 2015-11-04 | -$700.00K 10-Q · filed 2015-11-04 | $9.47M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2015-06-27 | -$263.00K 10-Q · filed 2015-07-30 | -$480.00K 10-Q · filed 2015-07-30 | $9.69M derived: sum of 3 quarters · filed 2016-02-12 | $9.56M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2015-03-28 | -$217.00K 10-Q · filed 2015-04-30 | $9.95M derived: sum of 2 quarters · filed 2016-02-12 | $9.83M derived: sum of 3 quarters · filed 2016-02-12 | $9.70M derived: sum of 4 quarters · filed 2016-02-12 | ||
| 2014-12-27 | $10.17M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | $10.04M derived: sum of 2 quarters · filed 2016-02-12 | $9.92M derived: sum of 3 quarters · filed 2016-02-12 | $9.79M 10-K · filed 2016-02-12 | ||
| 2014-09-27 | -$125.00K 10-Q · filed 2015-11-04 | -$254.00K derived: sum of 2 quarters · filed 2015-11-04 | -$378.00K 10-Q · filed 2015-11-04 | -$7.55M derived: sum of 4 quarters · filed 2015-11-04 | ||
| 2014-06-28 | -$129.00K 10-Q · filed 2015-07-30 | -$253.00K 10-Q · filed 2015-07-30 | -$7.42M derived: sum of 3 quarters · filed 2015-07-30 | -$7.71M derived: sum of 4 quarters · filed 2015-07-30 | ||
| 2014-03-29 | -$124.00K 10-Q · filed 2015-04-30 | -$7.29M derived: sum of 2 quarters · filed 2015-04-30 | -$7.58M derived: sum of 3 quarters · filed 2015-04-30 | -$7.88M derived: sum of 4 quarters · filed 2015-04-30 | ||
| 2013-12-28 | -$7.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | -$7.46M derived: sum of 2 quarters · filed 2015-02-17 | -$7.76M derived: sum of 3 quarters · filed 2015-02-17 | -$8.00M 10-K · filed 2015-02-17 | $8.00M 10-K · filed 2014-02-25 | |
| 2013-09-28 | -$289.00K 10-Q · filed 2014-10-30 | -$590.00K derived: sum of 2 quarters · filed 2014-10-30 | -$832.00K 10-Q · filed 2014-10-30 | -$1.61M derived: sum of 4 quarters · filed 2014-10-30 | ||
| 2013-06-29 | -$301.00K 10-Q · filed 2014-08-07 | -$544.00K 10-Q · filed 2014-08-07 | -$1.32M derived: sum of 3 quarters · filed 2014-08-07 | -$1.54M derived: sum of 4 quarters · filed 2014-08-07 | ||
| 2013-03-30 | -$242.00K 10-Q · filed 2014-04-30 | $242.00K 10-Q · filed 2013-05-08 | -$1.02M derived: sum of 2 quarters · filed 2014-04-30 | -$1.24M derived: sum of 3 quarters · filed 2014-04-30 | -$1.47M derived: sum of 4 quarters · filed 2014-04-30 | |
| 2012-12-29 | -$780.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$996.00K derived: sum of 2 quarters · filed 2014-02-25 | -$1.23M derived: sum of 3 quarters · filed 2014-02-25 | -$1.58M 10-K · filed 2014-02-25 | ||
| 2012-09-29 | -$216.00K 10-Q · filed 2013-10-30 | -$449.00K derived: sum of 2 quarters · filed 2013-10-30 | -$799.00K 10-Q · filed 2013-10-30 | |||
| 2012-06-30 | -$233.00K 10-Q · filed 2013-07-31 | -$583.00K 10-Q · filed 2013-07-31 | ||||
| 2012-03-31 | $350.00K 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |